Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Trading Statement

27 Apr 2017 07:00

RNS Number : 4698D
Kingspan Group PLC
27 April 2017
 

Kingspan Group Plc

Trading Update

 

27 April 2017

 

Kingspan Group plc, the global leader in high performance insulation, building fabric, and solar integrated building envelopes, is issuing this Trading Update in advance of its Annual General Meeting which is being held today at 10.00am in Dublin.

Overall, Kingspan has experienced a good start to the year reflecting a combination of solid underlying markets and the acquisitions made in 2016 bedding down well. Group sales of €831.2m for the three month period to 31 March were 24% ahead of prior year (+26% pre-currency, +14% pre currency and acquisitions).

 

By market, the UK remains solid overall although is a little softer than at the turn of the year. Mainland European markets continue to show signs of recovery with decent volumes overall. The US market is a little more encouraging than conditions experienced towards the end of last year. The Middle East and Turkey regions are subdued, with Australia and its adjacent markets showing more positive signs. A feature of all markets has been ongoing raw material inflation and the associated recovery effort.

 

Insulated Panel sales revenues were up 32% (+33% pre-currency, +16% pre-currency and acquisitions). Volumes in most key end markets are positive with the key trading priority being margin. Light & Air contributed 6% to divisional sales in the quarter, on plan, and is an excellent addition to the Group's high performance product suite.

Insulation Board sales revenues were up 8% (+11% pre-currency) in the period. The Kooltherm® mix has been positive overall with raw material inflation experienced in all territories and the associated recovery underway. The Group's new Kooltherm® facility for the Australasian market was successfully commissioned in Melbourne during the period.

 

Access Floors sales revenues were up 6% (+8% pre-currency). US activity is subdued, as was the case last year. The UK is holding up well for the moment although the pipeline is indicating weakness towards the end of 2017.

 

Environmental sales revenues were up 13% (+21% pre-currency, 3% pre currency and acquisitions). Overall, the division has had a good start to the year with the Rainwater harvesting business in Australia a particular highlight.

 

Net debt at 31 March was €457m, an increase of €29m from the position at last year end reflecting, in the main, the seasonal investment in working capital. The Group's funding position is robust with €639m of committed undrawn facilities and cash balances.

 

Looking ahead, the order backlog across the Group overall points towards a solid first half for the business. The project pipeline is encouraging in most of our major markets, although trending weaker in the U.K. in recent weeks. The key trading priority is the pass through of increases in input costs, and the associated lag likely to persist in a tight supply environment into the second quarter, and perhaps beyond. As a consequence, likely sales growth in the first half is expected to outpace profit growth in the period. Overall, the Group remains well positioned given the breadth of our product and market mix, our development agenda over time, together with the ongoing advancement of our high performance technology.

 

Kingspan will issue its half-year financial report for the period ended 30 June 2017 on Friday 18 August 2017.

 

For further information contact:

 

Gene Murtagh, Chief Executive Officer Tel: +353 (0) 42 9698000

 

Geoff Doherty, Chief Financial Officer Tel: +353 (0) 42 9698000

 

Douglas Keatinge, Murray Consultants Tel: +353 (0) 1 4980300

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDQLFLDZFBBBZ
Date   Source Headline
31st Jan 20121:04 pmRNSDirector/PDMR Shareholding
30th Jan 20125:49 pmRNSHolding(s) in Company
30th Jan 20125:46 pmRNSHolding(s) in Company
27th Jan 20125:20 pmRNSHolding(s) in Company
9th Jan 20121:00 pmRNSBlocklisting Interim Review
3rd Jan 20121:00 pmRNSTotal Voting Rights
6th Dec 20113:13 pmRNSDirector/PDMR Shareholding
5th Dec 20115:48 pmRNSTotal Voting Rights
30th Nov 20114:53 pmRNSDirector/PDMR Shareholding - Amendment
30th Nov 20114:42 pmRNSTreasury Stock - Amendment
29th Nov 20113:58 pmRNSTreasury Stock
29th Nov 20113:56 pmRNSDirector/PDMR Shareholding
14th Nov 20117:00 amRNSInterim Management Statement
14th Oct 20114:44 pmRNSTotal Voting Rights
14th Oct 20114:07 pmRNSHolding(s) in Company
14th Oct 20114:06 pmRNSHolding(s) in Company
14th Oct 20113:59 pmRNSHolding(s) in Company
14th Oct 20113:56 pmRNSHolding(s) in Company
14th Oct 20113:39 pmRNSAnnual Information Update
1st Sep 20113:53 pmRNSDirector/PDMR Shareholding
1st Sep 201110:21 amRNSDirector Declaration
25th Aug 20115:27 pmRNSTreasury Stock
25th Aug 20115:23 pmRNSDirector/PDMR Shareholding
22nd Aug 20117:00 amRNSHalf Yearly Report
11th Aug 20117:00 amRNSUSD200 Million Private Placement
1st Jul 20117:00 amRNSBlocklisting Interim Review
1st Jun 201112:24 pmRNSTotal Voting Rights
23rd May 20113:12 pmRNSHolding(s) in Company
19th May 201110:01 amRNSInvestor and analyst site visit
17th May 20112:54 pmRNSHolding(s) in Company
12th May 201112:18 pmRNSAGM Results
12th May 20117:00 amRNSInterim Management Statement
3rd May 201111:07 amRNSTotal Voting Rights
13th Apr 201112:11 pmRNSMerger Update
1st Apr 20112:02 pmRNSAcquisition
21st Mar 20113:00 pmRNSMerger Update
21st Mar 20112:50 pmRNSDirector/PDMR Shareholding
1st Mar 20114:38 pmRNSDirector/PDMR Shareholding
28th Feb 20117:00 amRNSFinal Results
1st Feb 20119:38 amRNSTotal Voting Rights
19th Jan 20112:16 pmRNSNotice of Results
19th Jan 20117:00 amRNSAcquisition
10th Jan 201111:39 amRNSBlocklisting Interim Review
5th Jan 20111:31 pmRNSTotal Voting Rights
4th Jan 20115:23 pmRNSDirectorate Change
22nd Dec 20106:17 pmRNSDirector/PDMR Shareholding
6th Dec 201012:31 pmRNSHolding(s) in Company
1st Dec 20106:20 pmRNSTotal Voting Rights
15th Nov 20107:00 amRNSInterim Management Statement
11th Nov 20103:36 pmRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.